Shimayali Kaushal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shimayali Kaushal has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Dong-Kwon Lim
KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea
1 shared publication Han T. N. Nguyen
Department of Otolaryngology−Head and Neck Surgery, Division of Otology, Neurotology and Cranial Base Surgery
1 shared publicationHsuan-Chih Kuo
Department of Otolaryngology−Head and Neck Surgery, Division of Otology, Neurotology and Cranial Base Surgery
1 shared publicationJu Eun Cho
KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea
1 shared publication- Jung Bin Kim
Department of Neurology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea
1 shared publication Melanie Fisher
Department of Otolaryngology−Head and Neck Surgery, Division of Otology, Neurotology and Cranial Base Surgery
1 shared publication
Latest Publications
- 15 April 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (18) , 13636-13648
Targeted Surface-Enhanced Raman Scattering for Highly Accurate Identification of Bacterial Species and Finding Spectral Signatures with Explainable Artificial Intelligence
The analysis of complex Raman spectra from biological samples has traditionally relied on conventional chemometric-based methods, the performance of which has been further improved by artificial intelligence (AI). The accurate identification of bacteria is critical to preventing sepsis, even in advanced clinical settings. Among several methods, Raman scattering has shown great promise in overcoming the limitations of conventional approaches. Despite this promise, unresolved challenges remain in the optimization of SERS and interpretation of AI algorithms. In this study, we used colloidal Au and Ag nanoparticles (NPs) to obtain reproducible surface-enhanced Raman scattering (SERS) spectra of bacteria. We investigated the effects of ligands on plasmonic NPs and wavelength dependence in SERS-based bacterial identification. The analysis was conducted within the biological fingerprint region of 500-1300 cm-1. Using a deep neural network model, the targeted SERS approach with mannose-modified AuNPs under 532 nm excitation achieved a high classification accuracy (96.1%) for 14 bacterial species. In addition, we propose a framework designed to explain how AI algorithms accurately interpret Raman spectra. The normalized positive values of Shapley additive explanations (npSHAP) were utilized to identify the top five peaks as an AI-selected spectral barcode. The spectral signatures identified by the proposed framework are presented in a manner that is both intuitive and straightforward, facilitating a clear and precise interpretation of the bacterial classification process.
- 15 April 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (18) , 13636-13648
Targeted Surface-Enhanced Raman Scattering for Highly Accurate Identification of Bacterial Species and Finding Spectral Signatures with Explainable Artificial Intelligence
The analysis of complex Raman spectra from biological samples has traditionally relied on conventional chemometric-based methods, the performance of which has been further improved by artificial intelligence (AI). The accurate identification of bacteria is critical to preventing sepsis, even in advanced clinical settings. Among several methods, Raman scattering has shown great promise in overcoming the limitations of conventional approaches. Despite this promise, unresolved challenges remain in the optimization of SERS and interpretation of AI algorithms. In this study, we used colloidal Au and Ag nanoparticles (NPs) to obtain reproducible surface-enhanced Raman scattering (SERS) spectra of bacteria. We investigated the effects of ligands on plasmonic NPs and wavelength dependence in SERS-based bacterial identification. The analysis was conducted within the biological fingerprint region of 500-1300 cm-1. Using a deep neural network model, the targeted SERS approach with mannose-modified AuNPs under 532 nm excitation achieved a high classification accuracy (96.1%) for 14 bacterial species. In addition, we propose a framework designed to explain how AI algorithms accurately interpret Raman spectra. The normalized positive values of Shapley additive explanations (npSHAP) were utilized to identify the top five peaks as an AI-selected spectral barcode. The spectral signatures identified by the proposed framework are presented in a manner that is both intuitive and straightforward, facilitating a clear and precise interpretation of the bacterial classification process.
- Open Access
- 23 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (5) , 2245-2257
Matrix Metalloproteinase-9 (MMP-9) Activatable Gold Nanoparticles for In Situ Zymography and Diagnostics of Neurofibromatosis Type 2 (NF2) Tumors
Neurofibromatosis type 2-related schwannomatosis (NF2-SWN) is a devastating genetic tumor-disposition syndrome characterized by multiple nervous system neoplasms. A hallmark of NF2-SWN is bilateral vestibular schwannomas (VSs) that cause hearing loss, vertigo, and life-threatening brainstem compression. Current imaging methods detect NF2-associated VS often late in their development and could lead to delayed therapeutic interventions. Matrix metalloproteinase-9 (MMP-9) is a key protease involved in extracellular matrix remodeling and tumor progression in NF2-associated VS, making it an attractive molecular target for activity-based sensing. Here, we develop MMP-9 activatable gold nanoparticles (AuNPs) incorporating a protease-cleavable peptide to enable sensitive reporting of protease activity in VS tissue. Through systematic tuning of polyethylene glycol (PEG) linker length and peptide valency, we establish an AuNP configuration that exhibits both efficient enzymatic cleavage and selectivity for MMP-9 over other VS-associated proteases. In schwannoma tissue, nanoparticles distinguish tumor from healthy nerve with >95% accuracy and detect 2 mm tumorscorresponding, based on published VS growth rates, to detection approximately 23 months earlier than conventional MRIenabling substantially earlier intervention. Longitudinal measurement of nanoparticle activation further resolves changes in MMP-9 activity within the tumor in response to therapeutic intervention, illustrating the platform’s capacity in monitoring treatment response. Together, these findings establish MMP-9 activatable AuNP as a sensitive, spatially resolved diagnostic tool for NF2-SWN that complements imaging by directly quantifying protease activity in tumors that are inaccessible to biopsy.
- 23 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (5) , 2245-2257
Open AccessMatrix Metalloproteinase-9 (MMP-9) Activatable Gold Nanoparticles for In Situ Zymography and Diagnostics of Neurofibromatosis Type 2 (NF2) Tumors
Neurofibromatosis type 2-related schwannomatosis (NF2-SWN) is a devastating genetic tumor-disposition syndrome characterized by multiple nervous system neoplasms. A hallmark of NF2-SWN is bilateral vestibular schwannomas (VSs) that cause hearing loss, vertigo, and life-threatening brainstem compression. Current imaging methods detect NF2-associated VS often late in their development and could lead to delayed therapeutic interventions. Matrix metalloproteinase-9 (MMP-9) is a key protease involved in extracellular matrix remodeling and tumor progression in NF2-associated VS, making it an attractive molecular target for activity-based sensing. Here, we develop MMP-9 activatable gold nanoparticles (AuNPs) incorporating a protease-cleavable peptide to enable sensitive reporting of protease activity in VS tissue. Through systematic tuning of polyethylene glycol (PEG) linker length and peptide valency, we establish an AuNP configuration that exhibits both efficient enzymatic cleavage and selectivity for MMP-9 over other VS-associated proteases. In schwannoma tissue, nanoparticles distinguish tumor from healthy nerve with >95% accuracy and detect 2 mm tumorscorresponding, based on published VS growth rates, to detection approximately 23 months earlier than conventional MRIenabling substantially earlier intervention. Longitudinal measurement of nanoparticle activation further resolves changes in MMP-9 activity within the tumor in response to therapeutic intervention, illustrating the platform’s capacity in monitoring treatment response. Together, these findings establish MMP-9 activatable AuNP as a sensitive, spatially resolved diagnostic tool for NF2-SWN that complements imaging by directly quantifying protease activity in tumors that are inaccessible to biopsy.